CDX Tissue Sections for IHC Screening

    In antibody screening and drug development, high-quality tissue sections and immunohistochemistry (IHC) control data are essential for reliable experimental results. We offer tissue sectioning services using allografted tumors, focusing on providing precise IHC controls for your antibody screening and drug development projects.

    We create stable grafted tumor models by transplanting in vitro cultured tumor cell lines into immunodeficient mice. These models have high tumor formation rates and consistency, and they produce tissue samples that closely resemble real tumors. We then process these grafted tumor tissues into sections and use advanced IHC techniques to provide accurate controls for your antibody screening.

    Our services offer:

    • Efficient and Reliable Grafted Tumor Models: Featuring a range of human-derived tumor cell lines to ensure diverse and applicable models.
    • Precise Tissue Sections: High-quality sectioning methods that maintain the integrity and accuracy of tissue structures.
    • Comprehensive IHC Controls: Standardized IHC control data to help you refine your antibody screening and validation process.

    We are dedicated to providing researchers with accurate and professional tissue sectioning and IHC control services, supporting your antibody screening and drug development, and ensuring the reliability of your research data.

    Find Your CDX Tissue Section!

    In-stock DiSliceX™ CDX Tissue Sections

    Type of tumorCatalog NumberProduct Name（DiSliceX）CellsRelevant targets
    Brain cancerSLI100009M-NSG U251 DiSliceX™ SlideSetU251CD63
    Breast cancerSLI100016M-NSG MDA-MB-231 DiSliceX™ SlideSetMDA-MB-231ROR1、AXL、CD73、HBEGF、VEGFA、LGALS1、CD63、CD142、NRG1、CD99、TGFBR2、CD63
    SLI100018M-NSG MCF-7 DiSliceX™ SlideSetMCF-7Her2、5T4、LIV-1、DDR1
    SLI100020M-NSG T47-D DiSliceX™ SlideSetT47-DCD63
    SLI100022M-NSG SK-BR-3 DiSliceX™ SlideSetSK-BR-3CSF1R、CD63
    Cervical cancerSLI100010M-NSG SiHa DiSliceX™ SlideSetSiHaCD63、LGALS1、ALPP、YAP1
    SLI100017M-NSG Hela DiSliceX™ SlideSetHelaMSLN、FOLR1、CD166、EPHA2、IGF-1R、CXCR4、B7H6、IGFBP7、LGALS1、CD63、B4GALT1
    Colorectal cancerSLI100007Balb/C nu HT55 DiSliceX™ SlideSetHT55CEACAM5、GUCY2C、Her3、EPCAM、CD73、CDH17、FZD10、GPA33、CD46
    Gastric cancerSLI100006Balb/C nu MKN45 DiSliceX™ SlideSetMKN45CEACAM5、MUC1
    SLI100014M-NSG SNU-5 DiSliceX™ SlideSetSNU-5ADAM9、CD63
    SLI100021M-NSG AGS DiSliceX™ SlideSetAGSCD81、ADAM9、CD63、JAM-A、CD99
    LeukemiaSLI100011M-NSG THP-1 DiSliceX™ SlideSetTHP-1CD33、CD93、B7H5、CCR2、CHI3L1、TREM2、CD70、BST1
    Liver cancerSLI100004Balb/C nu HuH7 DiSliceX™ SlideSetHuH7MSLN、Her3、GPC3、CDH6、CD24、ADAM9、AFP、SCF、ALB、ANGPTL3、CXADR、PRLR、CD112、CLU、B7H3、CLDN6
    SLI100019M-NSG HepG2 DiSliceX™ SlideSetHepG2ASGR1、CD63、AFP、ALB
    Lung cancerSLI100012M-NSG NCI-H82 DiSliceX™ SlideSetNCI-H82CD63
    LymphomaSLI100008M-NSG Daudi DiSliceX™ SlideSetDaudiCD45
    SLI100013M-NSG RAJI DiSliceX™ SlideSetRAJICD19、CD21、CD22、CD48、CD27、CD40、BAFF-R、CD79B、NTB-A、B7H6、CD205、CD74、CXCR5、CD10、PVRIG、CD23、B7H2、ICAM-1、CD70
    SLI100023M-NSG Hut78 DiSliceX™ SlideSetHut78CD45、LGALS1、CCR8
    MyelomaSLI100001M-NSG RPMI-8226 DiSliceX™ SlideSetRPMI-8226CD47、GPRC5D、CD138、CD38、CS1、BCMA、GPC1、CD30、CD33、GITR、TIM3、BTN3A1、MUC1、PDL-1、ICAM-1、CD99、CD63、CD147、TFRC、SELPLG
    SLI100002Balb/C nu MM.1S DiSliceX™ SlideSetMM.1SGPRC5D、CD138、CD38、KI67、BTN3A2、CCR1、CXCR3、CD164、SELPLG、CD147、LGALS1
    Ovarian cancerSLI100024M-NSG OVCAR3 DiSliceX™ SlideSetOVCAR3CD24
    Prostate cancerSLI100003Balb/C nu PC3 DiSliceX™ SlideSetPC3AXL、EPCAM、LGALS1、CD63
    SLI100015M-NSG LnCap DiSliceX™ SlideSetLnCapCD147
    Skin cancerSLI100005Balb/C nu A431 DiSliceX™ SlideSetA431Nectin4、Trop2、EGFR、CDH3、GPR87、PSCA、MICA、CDH1、PCSK、ADAM9、JAM-A、CD63、CD142

    Featured Data

    ihc-sli100022 sk br 3 ihc1
    ihc-sli100021 ags ihc1
    ihc-sli100020 t47 d ihc1
    ihc-sli100018 mcf 7 ihc1
    ihc-sli100001 rpmi 8226 ihc1

    Key Features:

    • Pre-Validated in IHC: Our tissue sections are validated with target-specific antibodies, ensuring reliable results for IHC studies.

    • Long-Term Stability: Sections maintain stability at room temperature for up to 3 years, providing lasting utility and consistency in research.

    • Derived from Tumor Models: Produced from tumor models in immunocompromised mice, these sections allow researchers to confidently assess antibody specificity and sensitivity, facilitating advancements in cancer diagnostics and therapeutics.

    • In-Stock Availability: Sections are readily available, allowing for immediate access and efficient planning in your research projects.